| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/20/2006 | EP1702624A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 09/20/2006 | EP1292621B1 Compositions for treating autoimmune disease |
| 09/20/2006 | CN1833723A Chain coccus recombination subunit vaccine and prepn. thereof |
| 09/19/2006 | US7109293 System for detecting protease |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/14/2006 | WO2006094665A1 Chimeric recombinant antigens of toxoplasma gondii |
| 09/14/2006 | WO2006094536A1 Targeted plasminogen activator fusion proteins as thrombolytic agents |
| 09/14/2006 | WO2004062619A3 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060204516 Compositions and methods for enhancing the immunogenicity of antigens |
| 09/14/2006 | US20060204514 Expression of hydrophobic proteins |
| 09/14/2006 | US20060204498 Novel antagonists of cxcr3-binding cxc chemokines |
| 09/14/2006 | CA2601271A1 Targeted plasminogen activator fusion proteins as thrombolytic agents |
| 09/14/2006 | CA2599620A1 Chimeric recombinant antigens of toxoplasma gondii |
| 09/14/2006 | CA2599577A1 Nucleic acids and proteins and methods for making and using them |
| 09/13/2006 | EP1700918A2 Activatable recombinant neurotoxins |
| 09/13/2006 | EP1700916A1 Novel centromeric protein shugoshin |
| 09/13/2006 | EP1700913A1 Fluorescent proteins |
| 09/13/2006 | EP1700868A2 A method for removing an antibody from blood or plasma |
| 09/13/2006 | EP1700867A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/13/2006 | EP1699826A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 09/13/2006 | EP1699822A2 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 09/13/2006 | EP1699492A2 Targeted immunogens |
| 09/13/2006 | EP1625152B1 Peptides modulating the activity of the engrailed transcription factor |
| 09/13/2006 | EP1363944B1 High-affinity antagonists of elr-cxc chemokines |
| 09/13/2006 | EP1088084B1 Erythropoietin analog-human serum albumin fusion protein |
| 09/13/2006 | EP0832093B1 Expression of lipoproteins |
| 09/13/2006 | EP0811065B1 Antagonists of interleukin-15 |
| 09/13/2006 | CN1833032A Improved method of amplifying atp and use thereof |
| 09/13/2006 | CN1831124A Method for preparing fusion protein contg. human interferon-alpha 2 and human seralbumin and its products |
| 09/13/2006 | CN1831123A Method for preparing fusion protein contg. human interferon-beta and human seralbumin and its products |
| 09/13/2006 | CN1831121A Method for structuring hybridoma cell system for anti-human monoclonal antibody of hepatitis B virus and its application |
| 09/13/2006 | CN1831012A Immunological adjuvant with immunity vegulating agent for treating and preventing diabetic from insulin-dependent |
| 09/13/2006 | CN1274717C Immune suppression fusion protein, its coded nucleic acid and application |
| 09/12/2006 | US7105650 Nucleotide sequences which code binding protein for use in taste simulation and food processing |
| 09/12/2006 | US7105484 GDNF receptorα |
| 09/12/2006 | US7105333 Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
| 09/08/2006 | WO2006093071A1 ANTI-IDIOTYPE ANTIBODY HAVING ANTIFUNGAL ACTIVITY ON FUNGUS CARRYING β-GLUCAN SYNTHASE AND UTILIZATION OF THE SAME |
| 09/08/2006 | CA2599240A1 Fgf growth factor analogs |
| 09/07/2006 | US20060198840 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 09/06/2006 | EP1696962A2 Novel glp-1 analogues linked to albumin-like agents |
| 09/06/2006 | EP0789762B1 Methods for the diagnosis of glaucoma |
| 09/06/2006 | CN1829734A Peptides capable of binding to titanium, silver and silicone |
| 09/06/2006 | CN1827649A Fusion toxin protein and uses thereof |
| 09/06/2006 | CN1827639A 新的细胞因子zalpha11配体 New cytokine zalpha11 Ligand |
| 09/06/2006 | CN1273601C Expression carrier for high-efficient screening target protein, its preparation method and use |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101973 β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 09/05/2006 | US7101972 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression |
| 09/05/2006 | US7101971 Erythropoietin analog-human serum albumin fusion |
| 09/05/2006 | US7101850 WISP polypeptides and nucleic acids encoding same |
| 09/05/2006 | US7101689 Interleukin-18 binding proteins, their preparation and use |
| 09/05/2006 | US7101677 detecting an effect on a membrane receptor by adding a compound to a cell expressing a membrane receptor/reporter fusion protein and detecting any change of said receptor/reporter fusion protein by detecting a signal from an active mutant receptor |
| 09/05/2006 | CA2178504C Immunoassays for prostate specific antigen |
| 08/31/2006 | WO2006090241A2 Method of creating or selecting recombinant genes |
| 08/31/2006 | WO2006089455A1 Targeting anti-tumour fusion protein containing adenovirus e4orf4 protein |
| 08/31/2006 | WO2006059105A3 Non-cytotoxic protein conjugates |
| 08/31/2006 | WO2006053613A3 Skin care composition comprising fusion polypeptide composition |
| 08/31/2006 | US20060195945 Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants |
| 08/31/2006 | US20060194950 separating antibodies from proteases; provide a mutated immunoglobulin-binding protein ligand that exhibits an improved stability at increased pH-values, and accordingly an improved tolerance to cleaning under alkaline conditions |
| 08/31/2006 | US20060194735 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 08/31/2006 | US20060194286 Apo-2LI and Apo-3 polypeptides |
| 08/31/2006 | US20060194282 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits |
| 08/31/2006 | US20060193876 Fusion proteins of Mycobacterium tuberculosis |
| 08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
| 08/30/2006 | EP1696031A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1696028A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/30/2006 | EP1696027A1 Hla-dr-binding antigen peptide derived from wt1 |
| 08/30/2006 | EP1695718A2 Biodegradable polyester and Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 08/30/2006 | EP1694845A1 Anticarcinoma antibidies and uses thereof |
| 08/30/2006 | EP1694709A1 Recombinant anti-cd64-immunotoxins |
| 08/30/2006 | EP1485128A4 Nanostructures containing antibody assembly units |
| 08/30/2006 | EP1423524B1 Method of protein production in plants |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1133558B1 Compositions and methods for increasing bone mineralization |
| 08/30/2006 | CN1826527A Methods for protein labeling based on acyl carrier protein |
| 08/30/2006 | CN1824680A BMP2/7 allodiploid structure analogue, its expression method and application |
| 08/29/2006 | US7098318 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity |
| 08/29/2006 | US7098312 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2006 | US7098184 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 08/29/2006 | US7098183 cell growth differentiation factors/polypeptides for immunization; animal models |
| 08/29/2006 | US7097965 Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein |
| 08/29/2006 | US7097841 Ferritin fusion proteins for use in vaccines and other applications |
| 08/29/2006 | CA2111238C Production of a protein of interest in the milk of a transgenic mammal |
| 08/24/2006 | WO2006086823A1 Molecules and chimeric molecules thereof |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060189558 Delivery of substances to cells |
| 08/24/2006 | US20060189531 Thrombopoietic compounds |
| 08/24/2006 | US20060188991 Flexible vaccine assembly and vaccine delivery platform |
| 08/24/2006 | US20060188963 Collectin-complement activating protein chimeras |
| 08/24/2006 | US20060188484 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188483 Virus vectors and methods of making and administering the same |
| 08/24/2006 | CA2597717A1 Antibodies against cxcr4 and methods of use thereof |
| 08/24/2006 | CA2597584A1 Molecules and chimeric molecules thereof |
| 08/23/2006 | EP1693457A2 Metastatic breast and colon cancer regulated genes |
| 08/23/2006 | EP1693385A1 Humanized anti-cd47 antibody |